Carmen Vigo‐Pelfrey

8.8k citations

18 papers · 7.3k indexed · 5 hit papers · h-index 18

Physiology top 0.1%
Molecular Biology top 2%
Pharmacology top 0.5%
Computational Theory and Mathematics top 0.5%
Cellular and Molecular Neuroscience top 2%

Co-authors: Ivan Lieberburg Dennis J. Selkoe Dale Schenk Christian Haass Albert Y. Hung Peter Seubert Martin Citron David B. Teplow
Topics: Alzheimer's disease research and treatments (14 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers)Dementia and Cognitive Impairment Research (5 papers)
Cited by: Physiology Biological Psychiatry Pharmacology
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Austria Sweden

In The Last Decade

Carmen Vigo‐Pelfrey

18 papers receiving 7.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyloid β-peptide is produced by cultured cells during normal metabolism

1992 1.6k citations Christian Haass, Michael G. Schlossmacher et al. Nature profile →
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

1992 1.5k citations Peter Seubert, Carmen Vigo‐Pelfrey et al. Nature profile →
Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

1992 1.4k citations Martin Citron, Tilman Oltersdorf et al. Nature profile →
Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease

1995 568 citations Ruth Motter, Carmen Vigo‐Pelfrey et al. Annals of Neurology profile →
Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains

1996 516 citations Yu‐Min Kuo, Mark R. Emmerling et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Carmen Vigo‐Pelfrey

Since Specialization

Citations

This map shows the geographic impact of Carmen Vigo‐Pelfrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Vigo‐Pelfrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Vigo‐Pelfrey more than expected).

Fields of papers citing papers by Carmen Vigo‐Pelfrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Vigo‐Pelfrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Vigo‐Pelfrey. The network helps show where Carmen Vigo‐Pelfrey may publish in the future.

Co-authorship network of co-authors of Carmen Vigo‐Pelfrey

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Vigo‐Pelfrey. A scholar is included among the top collaborators of Carmen Vigo‐Pelfrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Vigo‐Pelfrey. Carmen Vigo‐Pelfrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Cerebrospinal Fluid Levels of Amyloid Precursor Protein and Amyloid β-Peptide in Alzheimer’s Disease and Major Depression – Inverse Correlation with Dementia Severity 1998 ·European Neurology ·Christoph Höck,Sidonie Golombowski,F. Müller‐Spahn,(unknown),Konrad Beyreuther,Ursula Mönning,Dale Schenk,Carmen Vigo‐Pelfrey,Ashley I. Bush,Robert D. Moir,Rudolph E. Tanzi,John H. Growdon,Roger M. Nitsch	73
2	Glutamine Synthetase‐Induced Enhancement of β‐Amyloid Peptide Aβ(1–40) Neurotoxicity Accompanied by Abrogation of Fibril Formation and Aβ Fragmentation 1996 ·Journal of Neurochemistry ·Michael Y. Aksenov,Marina Aksenova,D. Allan Butterfield,K. Hensley,Carmen Vigo‐Pelfrey,John M. Carney	49
3	Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brainsbreakdown → 1996 ·Journal of Biological Chemistry ·Yu‐Min Kuo,Mark R. Emmerling,Carmen Vigo‐Pelfrey,(unknown),Joel B. Kirkpatrick,Geoffrey Murdoch,Melvyn J. Ball,Alex E. Roher	516
4	Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease 1995 ·Neurology ·Carmen Vigo‐Pelfrey,Peter Seubert,Robin Barbour,Charles H. Blomquist,(unknown),(unknown),F. Coria,Lei Chang,Barney E. Miller,Ivan Lieberburg,Dale Schenk	185
5	Amyloid β-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation 1995 ·Neuroscience Letters ·Lars Lannfelt,Hans Basun,Carmen Vigo‐Pelfrey,Lars‐Olof Wahlund,Bengt Winblad,Ivan Lieberburg,Dale Schenk	33
6	Cerebrospinal fluid levels of amyloid β‐protein in alzheimer's disease: Inverse correlation with severity of dementia and effect of apolipoprotein e genotype 1995 ·Annals of Neurology ·Roger M. Nitsch,G. William Rebeck,Meihua Deng,U. Ingrid Richardson,Marsha Tennis,Dale B. Schenk,Carmen Vigo‐Pelfrey,Ivan Lieberburg,Richard J. Wurtman,Bradley T. Hyman,John H. Growdon	94
7	Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's diseasebreakdown → 1995 ·Annals of Neurology ·Ruth Motter,Carmen Vigo‐Pelfrey,Dora Kholodenko,Robin Barbour,Kelly Johnson‐Wood,Douglas Galasko,L. Chang,Bruce L. Miller,Christopher M. Clark,(unknown),Darin E. Olson,Paula C. Southwick,(unknown),(unknown),Ivan Lieberburg,Peter Seubert,Dale Schenk	568
8	Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats 1995 ·Journal of Neuroscience ·(unknown),Ivan Lieberburg,Dale Schenk,Carmen Vigo‐Pelfrey,Keith L. Davis,Vahram Haroutunian	39
9	Increased β‐amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation 1994 ·FEBS Letters ·Janet Johnston,Richard F. Cowburn,Svante Norgren,Birgitta Wiehager,Nikolaos Venizelos,Bengt Winblad,Carmen Vigo‐Pelfrey,Dale Schenk,Lars Lannfelt,Cora O’Neill	112
10	Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. 1994 ·Proceedings of the National Academy of Sciences ·Martin Citron,Carmen Vigo‐Pelfrey,David B. Teplow,Christine Miller,D. Schenk,Jennifer Johnston,Bengt Winblad,Nikolaos Venizelos,Lars Lannfelt,D. J. Selkoe	272
11	Rapid Communication: Characterization of β‐Amyloid Peptide from Human Cerebrospinal Fluid 1993 ·Journal of Neurochemistry ·Carmen Vigo‐Pelfrey,(unknown),P S Keim,Ivan Lieberburg,Dale B. Schenk	340
12	Quality control of liposomal lipids with special emphasis on peroxidation of phospholipids and cholesterol 1993 ·Chemistry and Physics of Lipids ·Johanna K. Lang,Carmen Vigo‐Pelfrey	22
13	Amyloid β-peptide is produced by cultured cells during normal metabolismbreakdown → 1992 ·Nature ·Christian Haass,Michael G. Schlossmacher,Albert Y. Hung,Carmen Vigo‐Pelfrey,(unknown),Beth L. Ostaszewski,Ivan Lieberburg,Edward H. Koo,Dale Schenk,David B. Teplow,Dennis J. Selkoe	1606
14	Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi 1992 ·Journal of Clinical Microbiology ·Bo Ma,Bea Christen,Danny T. M. Leung,Carmen Vigo‐Pelfrey	119
15	Isolation and quantification of soluble Alzheimer's β-peptide from biological fluidsbreakdown → 1992 ·Nature ·Peter Seubert,Carmen Vigo‐Pelfrey,Fred Esch,Michael Lee,Harry F. Dovey,D. H. S. Davis,Sukanto Sinha,(unknown),(unknown),(unknown),Robert McCormack,Robert L. Wolfert,Dennis J. Selkoe,Ivan Lieberburg,Dale Schenk	1454
16	Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionbreakdown → 1992 ·Nature ·Martin Citron,Tilman Oltersdorf,Christian Haass,Lisa McConlogue,Albert Y. Hung,Peter Seubert,Carmen Vigo‐Pelfrey,Ivan Lieberburg,Dennis J. Selkoe	1395
17	Liposomes composed of partially hydrogenated egg phosphatidylcholines: fatty acid composition, thermal phase behavior and oxidative stability 1990 ·Chemistry and Physics of Lipids ·Johanna Lång,Carmen Vigo‐Pelfrey,Francis J. Martin	39
18	Membrane lipid oxidation 1990 ·Free Radical Biology and Medicine ·Carmen Vigo‐Pelfrey	335

About Carmen Vigo‐Pelfrey

Carmen Vigo‐Pelfrey is a scholar working on Physiology, Biochemistry and Psychiatry and Mental health, having authored 18 papers that have together received 7.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (14 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Dementia and Cognitive Impairment Research (5 papers). The work is most often cited by research in Physiology (6.1k citations), Biological Psychiatry (227 citations) and Pharmacology (1.5k citations). Carmen Vigo‐Pelfrey has collaborated with scholars based in United States, Austria and Sweden. Frequent co-authors include Ivan Lieberburg, Dennis J. Selkoe, Dale Schenk, Christian Haass, Albert Y. Hung, Peter Seubert, Martin Citron, David B. Teplow, Tilman Oltersdorf and Lisa McConlogue. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact